The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55.
Subject: Arthritis - PUBLISHED VIA Neuroscience Letters
Author(s):
Schuelert N, McDougall JJ
View Source >>
(Price: $36)
Related Studies:
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
Published via Proceedings of the National Academy of Sciences of the United States of America
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Published via Rheumatology
Involvement of the endocannabinoid system in osteoarthritis pain.
Published via European Journal of Neuroscience